Seaport Therapeutics, the startup launched earlier this year by the team behind Karuna Therapeutics, has raised another $225 million just six months after its most recent fundraising round.

Outside the accident and emergency department in Coventry is a man in a wheelchair. He is in a pitiful state. His legs and feet are swollen, causing him intense pain, but more than anything else ...

AstraZeneca has licensed a small-molecule lipoprotein disruptor from China’s CSPC Pharmaceutical Group for $100 million. The molecule is intended to prevent formation of lipoprotein(a), high ...

Preston North End heaped further misery on out-of-form Coventry City with a narrow 1-0 Championship win at Deepdale. Centre forward Emil Riis' 72nd-minute goal was enough to separate the sides and ...

Emil Riis ensured Preston's unbeaten home record under Paul Heckingbottom continued as the Lilywhites beat Coventry 1-0 in the Sky Bet Championship. The 26-year-old headed home a 72nd-minute ...

They did arrive back at different times, so Coventry have had to manage that dynamic. Jake Bidwell will be missing, but the defender’s injury is not as bad as the Sky Blues initially feared.

This discussion is particularly relevant given the recent approval of BMY's KarXT and the data from Neurocrine (NASDAQ:NBIX)'s phase 2 NBI-568. Investors are speculating on whether emraclidine's ...

Coventry City manager Mark Robins says he and his staff have been working on getting the players to "free up their heads and brains" as they try to end their poor start to the season. The Sky ...

Johnson & Johnson reported third-quarter results before the stock market opened on Tuesday, Oct. 15. Johnson & Johnson raised its sales outlook but lowered its guidance range for adjusted earnings ...

Preston North End entertain Coventry City at Deepdale in the EFL Championship on Saturday, October 15 at 12.30 pm. Did you know with a Digital Subscription to Lancashire Evening Post, you can get ...

MANCHESTER, England, Oct. 15, 2024 /PRNewswire/ -- Monument Therapeutics, a precision neuroscience company, today announced a further £1M equity investment by the Forster Foundation, a charitable ...

Last year, Bristol Myers Squibb spent $14 billion to acquire Karuna, a small biotech company that developed KarXT. Boston-based Karuna licensed the drug from Eli Lilly in 2012. Lilly developed its ...